Biomarkers such as leptin, adiponectin, and certain inflammatory cytokines (e.g., IL‐6 and TNF‐α) have shown promise in predicting the risk of obesity and its associated complications. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.